Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Innovate Biopharmaceuticals, Inc. (NASDAQ: INNT).

Full DD Report for INNT

You must become a subscriber to view this report.


Recent News from (NASDAQ: INNT)

Innovate Biopharmaceuticals to Highlight Progress in Celiac Disease and NASH at BIO CEO & Investor Conference on Monday, February 12, 2018 at 3:30PM ET
Innovate Biopharmaceuticals to Highlight Progress in Celiac Disease and NASH at BIO CEO & Investor Conference on Monday, February 12, 2018 at 3:30PM ET
Source: OTC Markets
Date: February, 07 2018 00:00
Innovate Biopharmaceuticals Announces Trading Under New Ticker Symbol INNT is Anticipated to Begin on Thursday, February 1, 2018
Innovate Biopharmaceuticals Announces Trading Under New Ticker Symbol INNT is Anticipated to Begin on Thursday, February 1, 2018
Source: OTC Markets
Date: January, 31 2018 00:00
CORRECTING and REPLACING - Innovate Biopharmaceuticals Announces Successful Merger Completion
CORRECTING and REPLACING - Innovate Biopharmaceuticals Announces Successful Merger Completion
Source: OTC Markets
Date: January, 30 2018 00:00
Monster Digital and Innovate Biopharmaceuticals Extend Outside Closing Date for Merger
Monster Digital and Innovate Biopharmaceuticals Extend Outside Closing Date for Merger
Source: OTC Markets
Date: January, 04 2018 00:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-1546,95789,87252.2488Short
2018-08-1457,473122,60746.8758Short
2018-08-13126,781216,67558.5121Short
2018-08-10103,516203,97250.7501Short
2018-08-09252,670371,35468.0402Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on INNT.


About Innovate Biopharmaceuticals, Inc. (NASDAQ: INNT)

Logo for Innovate Biopharmaceuticals, Inc. (NASDAQ: INNT)

Action Sports Camera and Memory Device Sales

 

Contact Information

 

 

Current Management

  • David H. Clarke / CEO
  • David Olert / CFO
  • Steven Barre / Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
  • Jonathan Clark /
  • Robert B. Machinist / Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
  • Christopher Miner / Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member

Current Share Structure

  • Market Cap: $390,770,453 - 05/17/2018
  • Authorized: 350,000,000 - 04/06/2018
  • Issue and Outstanding: 25,691,680 - 04/06/2018

 



Daily Technical Chart for (NASDAQ: INNT)

Daily Technical Chart for (NASDAQ: INNT)


Stay tuned for daily updates and more on (NASDAQ: INNT)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: INNT)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in INNT is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of INNT and does not buy, sell, or trade any shares of INNT. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/